Nephros, Inc.
NEPH
$1.63
$0.00990.61%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.18% | -7.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.18% | -7.67% | |||
| Cost of Revenue | 2.16% | 0.37% | |||
| Gross Profit | 12.40% | -12.57% | |||
| SG&A Expenses | -11.33% | -9.38% | |||
| Depreciation & Amortization | 0.00% | 3.03% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.20% | -4.11% | |||
| Operating Income | 164.98% | -58.50% | |||
| Income Before Tax | 163.32% | -71.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 163.32% | -71.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 163.32% | -71.01% | |||
| EBIT | 164.98% | -58.50% | |||
| EBITDA | 184.75% | -69.88% | |||
| EPS Basic | 163.27% | -70.81% | |||
| Normalized Basic EPS | 162.79% | -70.30% | |||
| EPS Diluted | 163.27% | -37.50% | |||
| Normalized Diluted EPS | 162.79% | -70.30% | |||
| Average Basic Shares Outstanding | 0.33% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.68% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
